Health

Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health

New report shows how long term investment in novel products like cell and gene therapies is beginning to bear fruit. The concern now is the price of these products and ensuring patients get access